#00386
Use ozonation, activated carbon, advanced oxidation, membranes, or source-specific pretreatment at high-risk facilities after effective conventional treatment, with monitoring of antibiotic residues, resistant bacteria, resistance genes, and treatment by-products.
Arnaud Gissinger · 10d ago · approved by Arnaud Gissinger 10d ago